September 27, 2013 at 14:38 PM EDT
Debt Limit Concerns Sink Stocks

Federal debt limit concerns sent the markets tumbling during the midday with the Dow dropping 75 points to 15,252. Nasdaq slipped 3 points to 3783.

On the upside

Halozyme Therapeutics (Nasdaq: HALO) received a $10 million milestone payment from Roche for launching the breast cancer treatment Herceptin SC in Europe.

Shares of RingCentral (NYSE: RNG) leaped in its market debut.

Magnum Hunter (NYSE: MHR) chairman and chief executive Gary C. Evans will present at the IPAA Oil & Gas Investment Symposium on Monday, September 30, 2013.


On the downside


Shares of Violin Memory (NYSE: VMEM) tumbled on its first trading day.

Nektar Therapeutics (Nasdaq: NKTR) reported disappointing results from a Phase 2 study of its pain treatment NKTR-181.

Insurance Insider wrote that Tower Group (Nasdaq: TWGP) hired several banks to assist the company in solving its reserving crisis.

In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 lost 7 points to 1691.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here